A digital health solution can be clinically validated and widely adopted in the UK, yet still face significant barriers to adoption in France.

At first glance, this seems counterintuitive. If a solution has strong clinical evidence, positive patient outcomes and successful implementation within the NHS, why wouldn't it be welcomed elsewhere?

Because healthcare adoption is rarely driven by evidence alone.

French healthcare professionals want to understand how a solution fits into their own practice, care pathways and healthcare environment.

The question is often less about whether a solution works than whether it makes sense within the realities of the French healthcare system.

This is why localisation in healthcare goes far beyond language. It is about understanding how trust is built, how clinical decisions are made and how innovation is integrated into everyday patient care.

The technology may be the same.

The healthcare culture is not.